Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.
RAR-related orphan receptor A (RORA): A new susceptibility gene for multiple sclerosis.
Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.
Poster 200 Demyelinating Polyneuropathy Post-Operatively in a Patient with Squamous Cell Carcinoma of the Tongue: A Case Report.
Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2'-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks.
Brain activation changes during locomotion in middle-aged to older adults with multiple sclerosis.
Mortality in Hungarian patients with multiple sclerosis between 1993 and 2013.
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
The Differential Effects of Alcohol and Nicotine-Specific Nitrosamine Ketone on White Matter Ultrastructure.
[May neuroimaging findings of a child with multiple sclerosis surprise us? Clinical and radiological observation].
The N-MOmentum trial: Building momentum to advance trial methodology in a rare disease.
Episomal Induced Pluripotent Stem Cells Promote Functional Recovery of Transected Murine Peripheral Nerve.
Hospitalization, Inpatient burden and comorbidities associated with bullous pemphigoid in the United States.
Brain structural connectivity in late-life major depressive disorder.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.
Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.
Potential application of lithium in Parkinson's and other neurodegenerative diseases.
Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia.
Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.
Relationships between trunk performance, gait and postural control in persons with multiple sclerosis.
Poster 347 Physical Therapy Utilization in the Management of Multiple Sclerosis in the United States.
Pages
« first
‹ previous
…
765
766
767
768
769
770
771
772
773
…
next ›
last »